Transurethral microwave thermotherapy for treatment of benign prostatic hyperplasia

Abstract

Many urologists have a high regard for the usefulness of transurethral microwave therapy (TUMT) in treating patients with lower urinary tract symptoms caused by benign prostatic hyperplasia. This therapy has been examined clinically in many centers throughout the world. The rationale for its effect on symptoms is unlike many of the other so-called minimally invasive treatment modalities. The improvement in symptoms and voiding function is greater with transurethral microwave thermotherapy than with drug therapy, and the associated morbidity is low. It also offers greater versatility than drug therapy, allowing patients with severe baseline symptoms and small prostates to be treated successfully. In addition, there has been an evolution in the technology of TUMT from low-energy to high-energy application indicating that this technique has a future in the treatment of lower urinary tract symptoms.

Use of Microwave in Processing of Drug Delivery Systems

“…There is a widespread use of microwave in food [20][21][22], microbiological [20][21][23][24][25][26], biomedical [27][28][29][30], analytical [31][32][33] and drug discovery [34][35][36] applications. In the recent decade, the microwave has been utilized to process dosage forms such as polymeric gel beads [19,[37][38][39], microspheres [40], nanomatrix [41], agglomerates [4,[42][43][44][45][46][47][48], tablet [13,50], film coat [51] and solid dispersion [52].…”